Phase I clinical trial of Wilms tumor 1 peptide vaccination for patients with advanced cancer
Phase 1
- Conditions
- advanced cancer
- Registration Number
- JPRN-UMIN000002771
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnant female Patient with severe underlying disease Patient with severe allergy disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safty of WT1 peptide vaccination with / without adjuvant (GM-CSF or CpG)
- Secondary Outcome Measures
Name Time Method Efficacy of WT1 peptide vaccination with / without adjuvant (GM-CSF or CpG)